1. Home
  2. VCEL vs CHCO Comparison

VCEL vs CHCO Comparison

Compare VCEL & CHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • CHCO
  • Stock Information
  • Founded
  • VCEL 1989
  • CHCO 1957
  • Country
  • VCEL United States
  • CHCO United States
  • Employees
  • VCEL N/A
  • CHCO N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • CHCO Major Banks
  • Sector
  • VCEL Health Care
  • CHCO Finance
  • Exchange
  • VCEL Nasdaq
  • CHCO Nasdaq
  • Market Cap
  • VCEL 1.8B
  • CHCO 1.8B
  • IPO Year
  • VCEL 1997
  • CHCO N/A
  • Fundamental
  • Price
  • VCEL $36.28
  • CHCO $118.81
  • Analyst Decision
  • VCEL Strong Buy
  • CHCO Hold
  • Analyst Count
  • VCEL 6
  • CHCO 3
  • Target Price
  • VCEL $58.60
  • CHCO $132.33
  • AVG Volume (30 Days)
  • VCEL 563.8K
  • CHCO 73.6K
  • Earning Date
  • VCEL 11-06-2025
  • CHCO 10-22-2025
  • Dividend Yield
  • VCEL N/A
  • CHCO 2.93%
  • EPS Growth
  • VCEL 2045.40
  • CHCO 11.27
  • EPS
  • VCEL 0.13
  • CHCO 8.68
  • Revenue
  • VCEL $249,119,000.00
  • CHCO $307,880,000.00
  • Revenue This Year
  • VCEL $18.35
  • CHCO $9.60
  • Revenue Next Year
  • VCEL $22.26
  • CHCO $1.36
  • P/E Ratio
  • VCEL $272.85
  • CHCO $13.70
  • Revenue Growth
  • VCEL 16.13
  • CHCO 6.33
  • 52 Week Low
  • VCEL $29.24
  • CHCO $102.22
  • 52 Week High
  • VCEL $63.00
  • CHCO $137.28
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 56.70
  • CHCO 43.53
  • Support Level
  • VCEL $33.76
  • CHCO $116.04
  • Resistance Level
  • VCEL $37.00
  • CHCO $119.31
  • Average True Range (ATR)
  • VCEL 1.48
  • CHCO 2.51
  • MACD
  • VCEL 0.05
  • CHCO -0.07
  • Stochastic Oscillator
  • VCEL 81.35
  • CHCO 31.68

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

Share on Social Networks: